Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01704326 · ClinicalTrials.gov registry record
A Study of Patients Treated With the Journey Deuce Bicompartmental Knee System
A clinical trial, sponsored by Smith & Nephew.
- Completed
- Registry status
- 59
- Enrollment target
NCT01704326: Completed study, sponsored by Smith & Nephew.
NCT01704326 is a clinical trial that has completed, run by Smith & Nephew. The registered enrollment target is 59 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01704326 has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- 59 participants
- Enrollment target
Study Summary
This is a prospective, multicenter, consecutive clinical study of the Journey Deuce Knee System and is intended to evaluate the safety and effectiveness of the new device.
Primary Outcome
Assess knee pain, function and range of motion using the Knee Society Clinical Rating System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2006-09 |
| Est. Completion | 2012-05 |
What the finished NCT01704326 record still lists
NCT01704326 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 59 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01704326 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01704326 about?
NCT01704326 is a clinical study titled "A Study of Patients Treated With the Journey Deuce Bicompartmental Knee System". This is a prospective, multicenter, consecutive clinical study of the Journey Deuce Knee System and is intended to evaluate the safety and effectiveness of the new device.
What is the current status of trial NCT01704326?
This trial is currently completed. The enrollment target is 59 participants. The study started on 2006-09. Estimated completion is 2012-05.
Who is sponsoring clinical trial NCT01704326?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia